Amin Firoozmand, Hematologist and medical oncologist in San Antonio, shared a post on LinkedIn:
“Tonight we had a research summit. This collaboration reflects the strength of coordinated expertise across institutions — all aligned toward one goal: expanding clinical trial access for patients with multiple myeloma, lymphoma, and leukemia.
Sarah Cannon Adult Stem Cell and Cellular Therapy
- Dr. Nosha Farhadfar
- Dr. Amin Firoozmand
- Dr. Tim Fenske
START Cancer Center
- Dr. Scot Ulmer
Texas Oncology
- Dr. John Renshaw
Sarah Cannon Research Institute
- Dr. Stephen Strickland – Director of Leukemia Research (Nashville)
Through this collaboration, our teams are ensuring that patients who progress through standard therapies – or who require novel investigational approaches – have access to advanced clinical trials close to home.
This is more than a meeting. It is a commitment to innovation, access, and the future of cellular therapy.”
More About Myeloma.
